Conference Proceedings

Disability Improvement Is Observed in Each Functional System in Alemtuzumab-Treated Patients With Active RRMS: Results From CARE-MS II Extension

Samuel F Hunter, Rany A Aburashed, Raed Alroughani, Steven M Bromley, Dominique Dive, Guillermo Izquierdo, Ho Jin Kim, Jan Lycke, Richard AL Macdonell, Carlo Pozzilli, Basil Sharrack, Patrick Vermersch, Andreas Lysandropoulos, Luke Chung, Nadia Daizadeh, Heinz Wiendl

NEUROLOGY | LIPPINCOTT WILLIAMS & WILKINS | Published : 2018

University of Melbourne Researchers

Grants

Funding Acknowledgements

Study Supported by: Sanofi and Bayer Healthcare Pharmaceuticals